免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

HemosIL纤维蛋白原-C;HemosIL纤维蛋白原-C XL

K号: K251968 · 2025-07-24

决定日期2025-07-24
产品代码KQJ
咨询委员会HE 请注意,由于您只提供了“HE”作为输入,我无法提供完整的翻译。请提供完整的描述或文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL is the device name listed in this FDA 510(k) record. The listed applicant is Instrumentation Laboratory (IL) Co.. It received FDA 510(k) clearance on 2025-07-24 under 510(k) number K251968. The device is classified under product code KQJ. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL?

HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL is a medical device that received FDA 510(k) clearance on 2025-07-24. The listed applicant is Instrumentation Laboratory (IL) Co.. The 510(k) number is K251968.

When did HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL receive FDA 510(k) clearance?

HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL received FDA 510(k) clearance on 2025-07-24, under 510(k) number K251968.

Who is the listed applicant for HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL?

The FDA 510(k) record lists Instrumentation Laboratory (IL) Co. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL?

The FDA product code for HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL is KQJ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Instrumentation Laboratory (IL) Co.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑